Natco Pharma gets court nod for insecticide launch; stock surges 4%
Natco Pharma plans to launch its CTPR products very shortly, which is estimated to have a market size of over ₹2,000 crore in India.
natco pharma company
September 2022
March 2022
November 2021
Natco Pharma shares jump 9% in early trade; here’s why
Natco Pharma shares surged after the drug maker unveiled the first generic version of oral cancer drug Revlimid in the U.S. market.
Soft opening seen for Sensex, Nifty; Tata Motors, L&T, Ashok Leyland, Natco Pharma in focus
The BSE Sensex and the NSE Nifty are pointing to modest opening losses, following muted cues from Asia peers and bearish trends on SGX Nifty futures.
Competitors Within
Home-grown smaller players are giving biggies a run for their money in the US generics market.
